Annual congress SATW

Faced with the increasing demand for new healthcare solutions, the need for innovative processes in the pharmaceutical industry is accelerating. This conference will explore how the integration of advanced technologies, such as Artificial Intelligence (AI) and Quantum Computing, is reshaping pharmaceutical research and development. Discover the tools of tomorrow that will transform how medicines are designed, developed, and brought to patients.

Program
12:30: Guest reception
13:00: Welcome address:

• Benoît Dubuis, President of the Swiss Academy of Engineering Sciences SATW
• Falko Schlottig, Director of the FHNW School of Life Sciences

How can Quantum Computing enable simulations and calculations that are not possible with classical computers in the pharmaceutical industry?

13:20: Keynotes:

• Alessandro Curioni, IBM Research
• Annalisa Pawlosky, Google

14:05: Panel discussion:

• Frederik Flöther, QuantumBasel
• Clément Javerzac, FHNW
• Andreas Masuhr, Swiss Quantum Initiative
• Annalisa Pawlosky, Google
• Moderation: Benoît Dubuis

14:40: Break

15:10: Pitch session:

• Olivier Tonneau, Quantonation
• Clément Javerzac, Quardiopm
• Martin Hofmann, Terra Quantum
• Moderation: Clément Javerzac

How is Artificial Intelligence shaping pharmaceutical R&D and accelerating development processes?

16:00: Keynotes:

• Stephan Palzer, Nestlé
• Jurgi Camblong, Sophia Genetics

16:30: Conclusion and Outlook

16:35: Welcome of new members SATW 2025

17:00: Farewell and Outlook

17:10: Apéro and Networking

In addition to the conference, there will be a Tech Fair where researchers, companies and start-ups will showcase their latest technologies and innovations. This is an excellent opportunity to learn about the latest developments and make valuable contacts.

Innovation at the crossroads
The pharmaceutical industry is at a turning point. New, bold approaches are needed to meet the growing demand for effective healthcare solutions. Therapies are still unavailable for many complex illnesses. Observation and analysis are increasingly giving way to innovative technologies which aim to shorten development cycles and achieve progress.

Technological progress is the driving force
Artificial intelligence (AI) and quantum computing play a central role here. AI processes enormous volumes of data, optimises research processes and improves the predictability of therapeutic success. Quantum computers will open up innovative opportunities for molecular modelling, the simulation of complex reactions and the discovery of new and cost-effective drugs.

Synergies for precision medicine
The convergence of both technologies opens up enormous potential. AI in data processing predicts patients' reactions to medication, while quantum computing is overcoming the existing limits of AI in terms of computing power and complexity. This synergy can significantly advance the development of more precise, personalised medicine.

Exploring interfaces, shaping the future
The Annual Congress SATW 2025 is dedicated to the impact of these technologies on pharmaceutical research. Experts will show how AI and quantum information science can work together, reduce clinical risks and accelerate the development of new drugs.

Connecting experts, strengthening collaboration
The conference offers a unique platform for networking leading minds in the areas of pharmaceuticals, AI and quantum research and facilitating an inspiring exchange regarding common challenges, new perspectives and concrete routes to integrated, future-oriented R&D.